story of the week
2 Weeks On, 1 Week Off Sunitinib Scheduling in Patients With Metastatic RCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase II Study of Two Weeks On, One Week Off Sunitinib Scheduling in Patients With Metastatic Renal Cell Carcinoma
J. Clin. Oncol 2018 Apr 11;[EPub Ahead of Print], E Jonasch, RS Slack, DM Geynisman, E Hasanov, MI Milowsky, WK Rathmell, S Stovall, D Juarez, TR Gilchrist, L Pruitt, MC Ornstein, ER Plimack, NM Tannir, BI RiniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.